THEMIS attenuates MASH by suppressing disease-associated hepatocyte induction and hepatocyte senescence in mice
- J Clin Invest. 2026 May 1;136(9):e199303. doi: 10.1172/JCI199303.
- 1. Life Sciences Institute and Department of Cell & Developmental Biology, University of Michigan Medical Center, Ann Arbor, Michigan, USA.
- 2. Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- 3. Center for Transcriptional Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Hepatocyte senescence is increasingly recognized as a pathogenic driver of metabolic dysfunction-associated steatohepatitis (MASH). Through single-nucleus transcriptomic profiling, we identified a discrete population of disease-associated hepatocytes (daHep) exhibiting enrichment for senescence markers in MASH livers. The emergence of senescent hepatocytes was associated with a marked induction of hepatic thymocyte selection associated (THEMIS) expression in both murine and human MASH. Genetic ablation of Themis, either globally or specifically in hepatocytes, resulted in significant expansion of daHep and senescent hepatocyte populations and exacerbated MASH pathology in mice. Single-nucleus transcriptomic analysis revealed a central role for THEMIS in shaping the cellular landscape of both parenchymal and nonparenchymal compartments within the MASH liver microenvironment. Conversely, adeno-associated virus-mediated overexpression of THEMIS suppressed hepatocyte senescence and attenuated diet-induced MASH. Mechanistic studies revealed that THEMIS deficiency promoted aberrant ERK phosphorylation and hepatocyte senescence. These findings establish THEMIS as a critical hepatoprotective factor that restrains hepatocyte senescence and mitigates metabolic liver disease progression.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
-
Research Areas: Cancer